Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients

NCT01720043 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
8
Enrollment
OTHER
Sponsor class

Stopped Slow Accrual

Conditions

Interventions

Sponsor

University of Utah